Expanded Access to Navitoclax
Latest Information Update: 09 May 2024
At a glance
- Drugs Navitoclax (Primary) ; Venetoclax
- Indications Crohn's disease; Myelofibrosis; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Expanded access; Therapeutic Use
- Sponsors AbbVie
- 26 Jul 2018 New trial record